Read + Share
Nierengarten MB. Potential new standard of care for the first-line treatment of metastatic
colorectal cancer: Interim analyses showed significantly better progression-free
survival outcomes with the combination regimen versus either chemotherapy alone
or nivolumab alo Cancer 2025;131:e35854.
PMID: 40377085
|
 |
|
